199 related articles for article (PubMed ID: 19361196)
1. Modulation of the transient receptor potential vanilloid channel TRPV4 by 4alpha-phorbol esters: a structure-activity study.
Klausen TK; Pagani A; Minassi A; Ech-Chahad A; Prenen J; Owsianik G; Hoffmann EK; Pedersen SF; Appendino G; Nilius B
J Med Chem; 2009 May; 52(9):2933-9. PubMed ID: 19361196
[TBL] [Abstract][Full Text] [Related]
2. Cardiac fibroblasts have functional TRPV4 activated by 4alpha-phorbol 12,13-didecanoate.
Hatano N; Itoh Y; Muraki K
Life Sci; 2009 Dec; 85(23-26):808-14. PubMed ID: 19879881
[TBL] [Abstract][Full Text] [Related]
3. Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms.
Cenac N; Altier C; Chapman K; Liedtke W; Zamponi G; Vergnolle N
Gastroenterology; 2008 Sep; 135(3):937-46, 946.e1-2. PubMed ID: 18565335
[TBL] [Abstract][Full Text] [Related]
4. The TRPV4 channel is a novel regulator of intracellular Ca2+ in human esophageal epithelial cells.
Ueda T; Shikano M; Kamiya T; Joh T; Ugawa S
Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G138-47. PubMed ID: 21493730
[TBL] [Abstract][Full Text] [Related]
5. Determinants of 4 alpha-phorbol sensitivity in transmembrane domains 3 and 4 of the cation channel TRPV4.
Vriens J; Owsianik G; Janssens A; Voets T; Nilius B
J Biol Chem; 2007 Apr; 282(17):12796-803. PubMed ID: 17341586
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium.
Vriens J; Owsianik G; Fisslthaler B; Suzuki M; Janssens A; Voets T; Morisseau C; Hammock BD; Fleming I; Busse R; Nilius B
Circ Res; 2005 Oct; 97(9):908-15. PubMed ID: 16179585
[TBL] [Abstract][Full Text] [Related]
7. Characterization of transient receptor potential vanilloid channel 4 (TRPV4) in human corneal endothelial cells.
Mergler S; Valtink M; Taetz K; Sahlmüller M; Fels G; Reinach PS; Engelmann K; Pleyer U
Exp Eye Res; 2011 Nov; 93(5):710-9. PubMed ID: 21996372
[TBL] [Abstract][Full Text] [Related]
8. Expression and functional characterization of transient receptor potential vanilloid-related channel 4 (TRPV4) in rat cortical astrocytes.
Benfenati V; Amiry-Moghaddam M; Caprini M; Mylonakou MN; Rapisarda C; Ottersen OP; Ferroni S
Neuroscience; 2007 Sep; 148(4):876-92. PubMed ID: 17719182
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of transient receptor potential vanilloid 4 channel suppresses abnormal activation of microglia induced by lipopolysaccharide.
Konno M; Shirakawa H; Iida S; Sakimoto S; Matsutani I; Miyake T; Kageyama K; Nakagawa T; Shibasaki K; Kaneko S
Glia; 2012 May; 60(5):761-70. PubMed ID: 22331560
[TBL] [Abstract][Full Text] [Related]
10. N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I.
Thorneloe KS; Sulpizio AC; Lin Z; Figueroa DJ; Clouse AK; McCafferty GP; Chendrimada TP; Lashinger ES; Gordon E; Evans L; Misajet BA; Demarini DJ; Nation JH; Casillas LN; Marquis RW; Votta BJ; Sheardown SA; Xu X; Brooks DP; Laping NJ; Westfall TD
J Pharmacol Exp Ther; 2008 Aug; 326(2):432-42. PubMed ID: 18499743
[TBL] [Abstract][Full Text] [Related]
11. Activation of urothelial transient receptor potential vanilloid 4 by 4alpha-phorbol 12,13-didecanoate contributes to altered bladder reflexes in the rat.
Birder L; Kullmann FA; Lee H; Barrick S; de Groat W; Kanai A; Caterina M
J Pharmacol Exp Ther; 2007 Oct; 323(1):227-35. PubMed ID: 17636010
[TBL] [Abstract][Full Text] [Related]
12. A transient receptor potential vanilloid 4 contributes to mechanical allodynia following chronic compression of dorsal root ganglion in rats.
Zhang Y; Wang YH; Ge HY; Arendt-Nielsen L; Wang R; Yue SW
Neurosci Lett; 2008 Feb; 432(3):222-7. PubMed ID: 18206306
[TBL] [Abstract][Full Text] [Related]
13. Functional mapping of the transient receptor potential vanilloid 1 intracellular binding site.
Johnson DM; Garrett EM; Rutter R; Bonnert TP; Gao YD; Middleton RE; Sutton KG
Mol Pharmacol; 2006 Sep; 70(3):1005-12. PubMed ID: 16763090
[TBL] [Abstract][Full Text] [Related]
14. Serotonin-induced activation of TRPV4-like current in rat intrapulmonary arterial smooth muscle cells.
Ducret T; Guibert C; Marthan R; Savineau JP
Cell Calcium; 2008 Apr; 43(4):315-23. PubMed ID: 17669489
[TBL] [Abstract][Full Text] [Related]
15. Antidipsogenic effects of a TRPV4 agonist, 4alpha-phorbol 12,13-didecanoate, injected into the cerebroventricle.
Tsushima H; Mori M
Am J Physiol Regul Integr Comp Physiol; 2006 Jun; 290(6):R1736-41. PubMed ID: 16439673
[TBL] [Abstract][Full Text] [Related]
16. Cell swelling, heat, and chemical agonists use distinct pathways for the activation of the cation channel TRPV4.
Vriens J; Watanabe H; Janssens A; Droogmans G; Voets T; Nilius B
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):396-401. PubMed ID: 14691263
[TBL] [Abstract][Full Text] [Related]
17. TRPV4.
Plant TD; Strotmann R
Handb Exp Pharmacol; 2007; (179):189-205. PubMed ID: 17217058
[TBL] [Abstract][Full Text] [Related]
18. A novel function of capsaicin-sensitive TRPV1 channels: involvement in cell migration.
Waning J; Vriens J; Owsianik G; Stüwe L; Mally S; Fabian A; Frippiat C; Nilius B; Schwab A
Cell Calcium; 2007 Jul; 42(1):17-25. PubMed ID: 17184838
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation on the Ser 824 residue of TRPV4 prefers to bind with F-actin than with microtubules to expand the cell surface area.
Shin SH; Lee EJ; Hyun S; Chun J; Kim Y; Kang SS
Cell Signal; 2012 Mar; 24(3):641-51. PubMed ID: 22101010
[TBL] [Abstract][Full Text] [Related]
20. Activation of TRPV4 strengthens the tight-junction barrier in human epidermal keratinocytes.
Akazawa Y; Yuki T; Yoshida H; Sugiyama Y; Inoue S
Skin Pharmacol Physiol; 2013; 26(1):15-21. PubMed ID: 23108102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
